Skip to main content
OpenTrials
Completed

NCT Number: NCT05721534

Deprescribing and Health-related Effects

In a primary care settled quality improvement project aiming to deprescribe medication through a medication review intervention, we investigated how the implemented medication changes affected health-related outcomes in real-life patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–105 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Aalborg University Hospital

Aalborg, 9000, Denmark

About this study

The project was approved by the Management in the Municipality of Frederikshavn. According to Danish legislation, no formal permission from the national or regional Committee on Health Research Ethics was required for this type of study, as patients were not treated inferior to usual care and no biological material was collected. It was conducted as a quality improvement project and informed consent was not required for the specific data collected. The study is in compliance with the General Data Protection Regulation and a part of North Denmark Region's record of processing activities (K2023-008).

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • new residents and residents that had not yet attended a consultation focusing on pharmacological treatment in The Chronic Care Model.
  • patients were invited for the consultation focusing on pharmacological treatment in the month of their birthday and, thereby, included randomly and consecutively throughout the study period.

Exclusion criteria

  • unable to collaborate on follow-up questionnaires

Treatment and study plan

Medication review

Other

Annual consultation focusing on pharmacological treatment. This specific consultation constituted the "intervention". It included a structured review of the patient's health state, in addition to a structured medication review with a focus on appropriate medication and deprescribing.

Other names: Medication review with focus on deprescribing

Primary outcomes

  1. self-reported health status

    Time frame: 4 months

    (on a scale from 1 to 10)

Secondary outcomes

  1. general condition

    Time frame: 4 months

    (rated on a 5-point Likert Scale)

  2. functional level

    Time frame: 4 months

    rated on a 5-point Likert Scale

Sponsors and collaborators

Lead sponsor

Anne Estrup Olesen

Other

Collaborators

  • Frederikshavn Kommune, Frederikshavn, Denmark
  • Lægeklinikken Frederikshavn, Frederikshavn, Denmark

Registry information

Official study title

Effective Deprescribing in Primary Care Without Deterioration of Health-related Outcomes

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Feb 10, 2023
Registry last updated
Feb 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.